Skip to main content

Advanced Human Imaging concludes Formal Agreements with Singapore based BizBaz Pte Ltd

SOUTH PERTH, Australia, April 04, 2022 (GLOBE NEWSWIRE) — Advanced Human Imaging Limited (ASX, NASDAQ: AHI) is pleased to update shareholders of the completion of the Master Services Agreement (“MSA” or “agreement”) with Singapore based digital health and financial intelligence platform BIZBAZ Pte Ltd (“BizBaz”).

The parties have executed the standard AHI MSA which entails the legal and contractual terms in which AHI agrees to grant BizBaz the right to use AHI’s licensed Software Development Kits (SDKs) for IOS and Android platforms for body circumference measurements, face scan measurements and related intellectual property once integrated into the BizBaz application/platform.

The MSA incorporates the following information and guidelines: commercial undertakings, software development kit, end user license, technology support, data processing agreement, fee schedule and professional services, including implementation support and training services, which are to be provided by AHI within the agreement with BizBaz.

The initial term of the MSA is for one year from commencement and will automatically extend for subsequent consecutive periods each of equivalent length to the initial term. Early termination procedures are included for either party to the MSA.

The financial impact of this MSA on AHI cannot be currently quantified and there are no minimum order requirements contained in the agreement.

About Bizbaz:

Bizbaz offers financial intelligence solutions to financial institutions, fintech and e-commerce companies in Asia, including comprehensive consumer and SME profiling and prescoring solutions, which enable them to engage the unbanked and underserved populations and organizations in Asia. Bizbaz products are built considering glades research and cutting-edge insight from behavioural sciences and leverage neural networks and other ML methodologies when collecting, analysing, and extracting insights.

With teams in Singapore, Israel, Vietnam, Philippines and Malaysia, Bizbaz offers a full suite of data-driven health and financial intelligence solutions, including but not limited to, comprehensive health and financial risk assessments, alternative credit scoring, fraud detection, eKYC, financial product aggregation and recommendation systems.

For more information on BizBaz, please visit: https://BizBaz.tech/

For related BizBaz ASX announcement on June 29th, 2021 please refer to:
https://wcsecure.weblink.com.au/pdf/AHI/02388966.pdf 

*This announcement has been approved by the CEO of Advanced Human Imaging Limited.

* Integration and timing of the Bizbaz application and platform launch are subject to BizBaz concluding all technical aspects required. AHI will provide all technical support and advice to assist BizBaz in reaching the target release timing but cannot control unknown delays in the delivery undertakings by its partners.

For more information contact:

Dr Katherine Iscoe
Chief Executive Officer
Advanced Human Imaging Limited
E: hello@ahi.tech
Vlado Bosanac
Strategy and Revenue
Advanced Human Imaging Limited
E: hello@ahi.tech

For more information please visit: https://www.ahi.tech/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.